Search Results - "Saullo, Francesca"

Abstract P376: The Monitoring by a Pharmacist Facilitator, of Side Effect, is Useful to Report Adverse Reactions Associated With Antihypertensive Agents in Practical Clinic in South Italy by Maretta, Alessia, Fersini, Giuseppina, Salerno, Valentina, Saullo, Francesca, Virno, Roberta, Spagnuolo, Vitaliano

“…Abstract only Adverse Drug Reactions (ADRs) are a serious health related problem, which can limit the treatment options, compliance and even leads to…”
Get full text

Constipation, what can hide? by Graziano, Francesca, Caloiero, Mimma, Saullo, Francesca

Get full text

A Comprehensive Safety Evaluation of Trabectedin and Drug–Drug Interactions of Trabectedin-Based Combinations by Leporini, Christian, Patanè, Marinella, Saullo, Francesca, Rende, Pierandrea, Gallelli, Luca, Di Paola, Eugenio Donato, Toscano, Rosa, Lucia, Maria, Rossi, Marco, De Sarro, Giovambattista, Russo, Emilio

“…Trabectedin (Yondelis ® ) is a potent marine-derived antineoplastic drug with high activity against various soft tissue sarcoma (STS) subtypes as monotherapy,…”
Get full text

Adverse Drug Reactions Related to Drug Administration in Hospitalized Patients by Gallelli, Luca, Siniscalchi, Antonio, Palleria, Caterina, Mumoli, Laura, Staltari, Orietta, Squillace, Aida, Maida, Francesca, Russo, Emilio, Gratteri, Santo, De Sarro, Giovambattista

“…Drug treatment may be related to the development of adverse drug reactions (ADRs). In this paper, we evaluated the ADRs in patients admitted to Catanzaro…”
Get more information

A questionnaire-based study in Calabria on the knowledge of off-label drugs in pediatrics by Saullo, Francesca, Saullo, Ernesto, Caloiero, Mimma, Menniti, Michele, Carbone, Claudia, Chimirri, Serafina, Paletta, Laura, Gallelli, Luca

“…Off-label use is very common among pediatricians, and the main cause is attributable to the lack of drugs specifically designed and marketed for children in…”
Get full text

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review by Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista

“…The epidermal growth factor receptor inhibitors (EGFRIs), cetuximab and panitumumab, represent an effective treatment option for patients affected by…”
Get full text

Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis by Giofrè, Chiara, Scicchitano, Francesca, Palleria, Caterina, Mazzitello, Carmela, Ciriaco, Miriam, Gallelli, Luca, Paletta, Laura, Marrazzo, Giuseppina, Leporini, Christian, Ventrice, Pasquale, Carbone, Claudia, Saullo, Francesca, Rende, Pierandrea, Menniti, Michele, Mumoli, Laura, Chimirri, Serafina, Patanè, Marinella, Esposito, Stefania, Cilurzo, Felisa, Staltari, Orietta, Russo, Emilio, De Sarro, Giovambattista

“…Pharmacovigilance (PV) is designed to monitor drugs continuously after their commercialization, assessing and improving their safety profile. The main…”
Get full text

Pharmacovigilance and drug safety in Calabria by Carbone, Claudia, Gallelli, Luca, Paletta, Laura, Patanè, Marinella, Marrazzo, Giuseppina, Leporini, Christian, Chimirri, Serafina, Mazzitello, Carmela, Menniti, Michele, Rende, Pierandrea, Palleria, Caterina, Saullo, Francesca, Staltari, Orietta, Ventrice, Pasquale, Mumoli, Laura, Cilurzo, Felisa, Esposito, Stefania, Scicchitano, Francesca, Ciriaco, Miriam, Group, The Univigil Cz, Giofrè, Chiara, Russo, Emilio, De Sarro, Giovambattista

Get full text

Pharmacovigilance and drug safety in Calabria : 2012 adverse events analysis by Giofrè, Chiara, Scicchitano, Francesca, Palleria, Caterina, Mazzitello, Carmela, Ciriaco, Miriam, Gallelli, Luca, Paletta, Laura, Marrazzo, Giuseppina, Leporini, Christian, Ventrice, Pasquale, Carbone, Claudia, Saullo, Francesca, Rende, Pierandrea, Menniti, Michele, Mumoli, Laura, Chimirri, Serafina, Patanè, Marinella, Esposito, Stefania, Cilurzo, Felisa, Staltari, Orietta, Russo, Emilio, De Sarro, Giovambattista, Group, The Univigil Cz

Get full text

Management of dermatologic toxicities associated with monoclonal antibody epidermal growth factor receptor inhibitors: A case review by Leporini, Christian, Saullo, Francesca, Filippelli, Gianfranco, Sorrentino, Antonio, Lucia, Maria, Perri, Gino, Gattuta, Gaetana La, Infusino, Stefania, Toscano, Rosa, Dima, Gianluca, Olivito, Virginia, Paletta, Laura, Bottoni, Ugo, De Sarro, Giovambattista

“…INTRODUCTIONThe epidermal growth factor receptor inhibitors (EGFRIs), cetuximab and panitumumab, represent an effective treatment option for patients affected…”
Get full text